+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heparin"

From
Antithrombotic Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Antithrombotic Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 199 Pages
  • Global
From
Thrombosis Drug Market - Global Forecast 2025-2032 - Product Thumbnail Image

Thrombosis Drug Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 184 Pages
  • Global
From
From
From
From
Cardiovascular Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cardiovascular Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 194 Pages
  • Global
From
Acute Coronary Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

Acute Coronary Syndrome Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 199 Pages
  • Global
From
Argatroban Market - Global Forecast 2025-2032 - Product Thumbnail Image

Argatroban Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 195 Pages
  • Global
From
Anticoagulants Market - Global Forecast 2025-2032 - Product Thumbnail Image

Anticoagulants Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 193 Pages
  • Global
From
Bivalirudin Market - Global Forecast 2025-2032 - Product Thumbnail Image

Bivalirudin Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 185 Pages
  • Global
From
Fondaparinux Market - Global Forecast 2025-2032 - Product Thumbnail Image

Fondaparinux Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
From
From
Thrombocytopenia Global Market Report 2025 - Product Thumbnail Image

Thrombocytopenia Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Antithrombotic Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Antithrombotic Drugs Market - Global Strategic Business Report

  • Report
  • November 2025
  • 282 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • November 2025
  • 158 Pages
  • Global
From
Anticoagulant Reversal Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticoagulant Reversal Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 140 Pages
  • Global
From
Loading Indicator

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more